BRD2 and major depressive disorder: Our main findings were that LH levels were significantly lower in the MDD group, menstrual duration and bleeding were significantly higher in the control group, FSH and E2 levels were significantly higher, and AMH and total AFC measurements were significantly lower in the MDD group after SSRI treatment compared to pretreatment.